These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 20506232)
1. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing? Sharples AP; Al-Shanti N; Stewart CE J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232 [TBL] [Abstract][Full Text] [Related]
2. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system. Al-Shanti N; Saini A; Faulkner SH; Stewart CE Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. Layne MD; Farmer SR Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. Meadows KA; Holly JM; Stewart CE J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. Foulstone EJ; Meadows KA; Holly JM; Stewart CE J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha. Fernández-Celemín L; Pasko N; Blomart V; Thissen JP Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1279-90. PubMed ID: 12388149 [TBL] [Abstract][Full Text] [Related]
7. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol. Saini A; Al-Shanti N; Sharples AP; Stewart CE Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model. Semsarian C; Sutrave P; Richmond DR; Graham RM Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):443-51. PubMed ID: 10191278 [TBL] [Abstract][Full Text] [Related]
9. Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha. Grohmann M; Foulstone E; Welsh G; Holly J; Shield J; Crowne E; Stewart C J Physiol; 2005 Oct; 568(Pt 1):229-42. PubMed ID: 16081485 [TBL] [Abstract][Full Text] [Related]
10. Myogenin, MyoD and IGF-I regulate muscle mass but not fiber-type conversion during resistance training in rats. Aguiar AF; Vechetti-Júnior IJ; Alves de Souza RW; Castan EP; Milanezi-Aguiar RC; Padovani CR; Carvalho RF; Silva MD Int J Sports Med; 2013 Apr; 34(4):293-301. PubMed ID: 23059557 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone stimulates mechano growth factor expression and activates myoblast transformation in C2C12 cells. Imanaka M; Iida K; Murawaki A; Nishizawa H; Fukuoka H; Takeno R; Takahashi Y; Okimura Y; Kaji H; Chihara K Kobe J Med Sci; 2008 May; 54(1):E46-54. PubMed ID: 18772608 [TBL] [Abstract][Full Text] [Related]
12. Pro- and anti-apoptotic roles for IGF-I in TNF-alpha-induced apoptosis: a MAP kinase mediated mechanism. Saini A; Al-Shanti N; Faulkner SH; Stewart CE Growth Factors; 2008 Oct; 26(5):239-53. PubMed ID: 18651291 [TBL] [Abstract][Full Text] [Related]
13. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha. Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516 [TBL] [Abstract][Full Text] [Related]
14. Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells. Sato M; Ito A; Kawabe Y; Nagamori E; Kamihira M J Biosci Bioeng; 2011 Sep; 112(3):273-8. PubMed ID: 21646045 [TBL] [Abstract][Full Text] [Related]
15. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6. Armand AS; Lécolle S; Launay T; Pariset C; Fiore F; Della Gaspera B; Birnbaum D; Chanoine C; Charbonnier F Exp Cell Res; 2004 Jul; 297(1):27-38. PubMed ID: 15194422 [TBL] [Abstract][Full Text] [Related]
16. Impaired muscle regeneration and myoblast differentiation in mice with a muscle-specific KO of IGF-IR. Heron-Milhavet L; Mamaeva D; LeRoith D; Lamb NJ; Fernandez A J Cell Physiol; 2010 Oct; 225(1):1-6. PubMed ID: 20458740 [TBL] [Abstract][Full Text] [Related]
17. Reduction of myoblast differentiation following multiple population doublings in mouse C2 C12 cells: a model to investigate ageing? Sharples AP; Al-Shanti N; Lewis MP; Stewart CE J Cell Biochem; 2011 Dec; 112(12):3773-85. PubMed ID: 21826704 [TBL] [Abstract][Full Text] [Related]
18. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity. Tolosa L; Morlá M; Iglesias A; Busquets X; Lladó J; Olmos G Cell Signal; 2005 Nov; 17(11):1333-42. PubMed ID: 16125053 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice. Ye P; Price W; Kassiotis G; Kollias G; D'Ercole AJ J Neurosci Res; 2003 Mar; 71(5):721-31. PubMed ID: 12584730 [TBL] [Abstract][Full Text] [Related]